Showing results (181-190 of 275) with videos related to
Sort By:
Pageof 28
The Australian and New Zealand Journal of Psychiatry|February 18, 2022
Changes in antidepressant use in Australia: A nationwide analysis (2015-2021)Juliana de Oliveira Costa, Malcolm B Gillies, Andrea L Schaffer, et al.Journal of the American Heart Association|June 29, 2023
Persistence and Adherence to Cardiovascular Medicines in AustraliaJuliana de Oliveira Costa, Jialing Lin, Sallie-Anne Pearson, et al.Pharmacoepidemiology and Drug Safety|November 14, 2018
Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based studyAndrea L Schaffer, Emily A Karanges, Nicholas A Buckley, et al.Pharmacoepidemiology and Drug Safety|February 22, 2019
Anticipating the effects of restricting high-dose preparations of strong opioids in Australia: A population-based analysis to inform the current policy debateDanni Zheng, Sujita W Narayan, Helga Zoega, et al.Journal of Patient Experience|December 13, 2021
From the Patient's Perspective: Orthopedic Virtual RoundsTonya Moyse, Erica Yates, Virgilio Fajardo, et al.Public Health Research & Practice|April 8, 2015
Manual versus automated coding of free-text self-reported medication data in the 45 and Up Study: a validation studyDanijela Gnjidic, Sallie-Anne Pearson, Sarah N Hilmer, et al.Cancer Epidemiology|June 24, 2015
Patterns of care and survival after a cancer of unknown primary (CUP) diagnosis: A population-based nested cohort study in Australian Government Department of Veterans' Affairs clientsAndrea L Schaffer, Sallie-Anne Pearson, Timothy A Dobbins, et al.Cancer Epidemiology|June 20, 2015
Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study in Australian Government Department of Veterans' Affairs clientsClaire M Vajdic, Andrea L Schaffer, Timothy A Dobbins, et al.CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 28, 2018
Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in AustraliaAndrea L Schaffer, Nicholas A Buckley, Louisa Degenhardt, et al.International Journal of Epidemiology|September 22, 2022
The association between psychostimulant use in pregnancy and adverse maternal and neonatal outcomes: results from a distributed analysis in two similar jurisdictionsXimena Camacho, Helga Zoega, Tara Gomes, et al.Pageof 28